
Merck's Dr Dave Maraldo explains that small-molecule platform agility and flexible conjugation capacity can help biologics manufacturing respond to research needs.
James Rorke, vice-president, operations, Steriline North America, discusses the benefits of automation in fill/finish operations.
James Rorke, vice-president, operations, Steriline North America, discusses the advantages of automation in fill/finish, particulary for low volume, high quaility products such as cell and gene therapies, for which minimizing product loss is crucial.
For more INTERPHEX 2023 video content, check






